Healthy At 100

Healthy At 100

Genetics firm 23andMe reaches out to the mass market, dropping the price of DNA analysis to $99. It aims to grow from a testing business into a data business — the “Google of personalized health care” — able to spot population groups most at risk for serious diseases. “You can target them with preventative messages, make sure they’re examined more frequently, and in the end live healthier lives”